If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.80
Bid: 0.75
Ask: 0.85
Change: 0.00 (0.00%)
Spread: 0.10 (13.333%)
Open: 0.80
High: 0.80
Low: 0.80
Prev. Close: 0.80
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

8 Jan 2024 16:24

RNS Number : 9988Y
N4 Pharma PLC
08 January 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BYW8QM32

Issuer Name

N4 PHARMA PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

IG Markets Limited

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

05-Jan-2024

6. Date on which Issuer notified

08-Jan-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

0.000000

3.208694

3.208694

8624339

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

 

Sub Total 8.A

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Equity swaps

Cash

8624339

3.208694

Sub Total 8.B2

8624339

3.208694%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

IG Group Holdings

IG Markets Limited

3.208694

3.208694%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

IG Markets Limited ('IGM') is a subsidiary of IG Group, the ultimate controlling person of which is IG Group Holdings plc. ('IGGH')IGM is 100% owned by IGGH through its subsidiaries, IG Group Ltd ('IGGL'), and Market Data Limited ('MDL').

12. Date of Completion

08-Jan-2024

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFLFFRLVITIIS
Date   Source Headline
24th Sep 20187:00 amRNSAcceptance of Nuvec® on EUNCL
20th Sep 20187:01 amRNSInterim Results
20th Sep 20187:00 amRNSStrategic Review
30th Jul 201811:05 amRNSSecond Price Monitoring Extn
30th Jul 201811:00 amRNSPrice Monitoring Extension
30th Jul 20187:00 amRNSChange of Adviser
17th Jul 20181:12 pmRNSHolding(s) in Company
11th Jul 20182:05 pmRNSSecond Price Monitoring Extn
11th Jul 20182:00 pmRNSPrice Monitoring Extension
9th Jul 20187:00 amRNSClinical trials preliminary results
18th Jun 20187:00 amRNSNuvec® Update
23rd May 201811:31 amRNSResult of AGM
9th May 20187:00 amRNSFiling of Patent
27th Apr 201811:00 amRNSPosting of Annual Report and Notice of AGM
25th Apr 20187:00 amRNSFinal Results
18th Apr 20187:00 amRNSCommencement of Sildenafil Clinical Trial
9th Apr 201811:00 amRNSPrice Monitoring Extension
9th Mar 20188:43 amRNSExercise of Warrants and Total Voting Rights
8th Mar 201810:05 amRNSHolding(s) in Company
8th Mar 20187:00 amRNSNuvec® Update
7th Mar 20188:33 amRNSExercise of Warrants and Total Voting Rights
2nd Mar 201812:17 pmRNSChange of Adviser
26th Feb 20189:27 amRNSExercise of Warrants and Total Voting Rights
21st Feb 20181:36 pmRNSExercise of Warrants and Total Voting Rights
19th Feb 20185:01 pmRNSExercise of Warrants and Total Voting Rights
14th Feb 20185:26 pmRNSExercise of Warrants and Total Voting Rights
13th Feb 201812:52 pmRNSExercise of Warrants and Total Voting Rights
12th Feb 20182:05 pmRNSSecond Price Monitoring Extn
12th Feb 20182:00 pmRNSPrice Monitoring Extension
12th Feb 201811:06 amRNSSecond Price Monitoring Extn
12th Feb 201811:00 amRNSPrice Monitoring Extension
8th Feb 201812:01 pmRNSHolding(s) in Company
8th Feb 201811:46 amRNSExercise of Warrants and Total Voting Rights
5th Feb 20187:00 amRNSIssue of Equity and Director/PDMR Shareholding
2nd Feb 20184:47 pmRNSExercise of Warrants and Total Voting Rights
2nd Feb 20181:04 pmRNSAward of Grant and Collaboration with MedImmune UK
30th Jan 20183:04 pmRNSExercise of Warrants and Total Voting Rights
24th Jan 20184:06 pmRNSExercise of Warrants and Total Voting Rights
24th Jan 20181:19 pmRNSGlobal Business Accelerator Programme in Japan
22nd Jan 201810:44 amRNSExercise of Warrants and Total Voting Rights
15th Jan 201812:36 pmRNSHolding(s) in Company
8th Jan 20182:31 pmRNSExercise of Warrants and Total Voting Rights
8th Jan 20181:26 pmRNSHolding(s) in Company
28th Dec 20179:03 amRNSExercise of Warrants and Total Voting Rights
22nd Dec 20177:00 amRNSFiling of Patent
18th Dec 20178:27 amRNSHolding(s) in Company
13th Dec 20174:07 pmRNSExercise of Warrants and Total Voting Rights
29th Nov 201711:12 amRNSViagra switch to OTC status in the UK
10th Nov 20174:04 pmRNSDirector/PDMR Shareholding
8th Nov 20177:00 amRNSResults of latest nuvec pre-clinical study

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.